Navigation Links
Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
Date:11/5/2007

MONTVALE, N.J., Nov. 5 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI) announced results of a series of preclinical studies designed to explain the mechanism underlying dysfunctional high density lipoprotein (HDL), that creates a defect in reverse cholesterol transport in patients with Diabetes Mellitus (DM). The studies reveal that a common blood protein, Haptoglobin, binds to the core of HDL and that a defective Haptoglobin variant (Hp2-2), found in 40% of the population, may induce dysfunctionality in HDL. Further, the studies report that exposure to Vitamin E can restore HDL functionality and the process of reverse cholesterol transport. The study is being presented today at the American Heart Association's (AHA) Scientific Sessions 2007 in Orlando, Florida.

"We are very pleased with the outcome of these studies, as we believe they provide scientific rationale for our current development platform, including our work developing a diagnostic test for Haptoglobin type, to determine cardiovascular risk and a therapeutic product to decrease HDL oxidation and restore reverse cholesterol transport function," said Noah Berkowitz, M.D., Ph.D., President and Chief Executive Officer of Synvista. "This study further demonstrates that the Hp2-2 phenotype, a risk factor for cardiovascular events in patients with diabetes, may function by interfering with the function of HDL and promoting inflammatory atherosclerosis."

The experiments of Rabea Asleh, M.D., of the Rappaport Faculty of Medicine and Research Institute, at the Technion, Haifa, Israel, who is today's recipient of the AHA's Council on Nutrition, Physical Activity and Metabolism's 2007 New Investigator Award, provided a mechanistic explanat
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
2. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
3. LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies
4. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
5. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
6. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
7. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
8. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
9. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
10. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
11. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...e/--Inadditiontofamily,friendsandhealth,cancersurv...anksgivinggratitudelist. ,, "Theyheardthefactsa...Monday,sverdictstotaling$103millionindamagesagains...womennationwidewhohavesuedWyethandPfizerpharmaceut...mpro.Wisneskiandtheothervictimsofhormonetherapyhav...
(Date:11/24/2009)...re/--PharmaceuticalInstitute,aleadingproviderofspe...otechindustry,todayannouncedthelaunchofanewe-cours...tplace e-courseisthenewestadditiontothecompany,s M...eriesofe-coursesdesignedtofillthecriticalneedforba...professionals. ,, Thenewthreemodule HospitalMar...
(Date:11/24/2009)...-USNewswire/--America,spharmaceuticalresearchandbi...estotreatorpreventHIV/AIDSandrelatedconditions,acc...ResearchandManufacturersofAmerica(PhRMA).December1...renesscampaignthatoriginatedatthe1988WorldSummitof..., "Wearegreatlyencouragedbythesecriticallyimport...
Breaking Medicine Technology:Maryland Woman Thankful for Wyeth Verdicts 2Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3Trapeze Networks Announces Trapeze Medical Bringing Medical Grade Mobility to Healthcare Market 58848 1Trapeze Networks Announces Trapeze Medical Bringing Medical Grade Mobility to Healthcare Market 58848 2ICFH Elects New Board Member Whilly Bermudez 58846 1ICFH Elects New Board Member Whilly Bermudez 58846 2New Government Research Finds One in Every 100 Children Has Autism of Whom Nearly 40 25 Are Recovered 58844 1New Government Research Finds One in Every 100 Children Has Autism of Whom Nearly 40 25 Are Recovered 58844 2
... with the Gynecologic Oncology Group -, BRISBANE,...ced it has expanded its clinical trials program th...y of its lead product candidate,BSI-201. The trial...ase,(PARP) inhibitor in the company,s DNA repair p...oma or malignant mixed mullerian tumors., This mu...
... May 28 NicOx S.A.,(Euronext Paris: COX) today an...e third pivotal phase 3 clinical trial for naproxc...the 303 study). 810 patients have been,randomized ...e in this,study, which is the final phase 3 trial ...of naproxcinod. The objective of this study is to ...
Other Medicine Technology:BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer 2NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study 2NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study 3NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study 4
(Date:11/25/2009).../PRNewswire/--Reportlinker.comannouncesthatanewmar... TheMarketforAnti-ageingFoods(2ndEdition) ,,...for-Anti-ageing-Foods-(2nd-Edition ).html ,, Th...astpacewithgrowthoutstrippingthatofconventionalfoo...hClaimsDirective,sstrictapproachtohealthclaimshowe...
(Date:11/25/2009)....25/PRNewswire/--HairFairies,the headlice help...intheholidayseasonwithaThanksgivingNitZapping(TM)g...877-285-0069willreceivetheirchoiceofafree,allnatur...ddition,HairFairieswilloffer50%offitswholerangeofs...aldiscountsareavailableonline. ,, Theholidaysar...
(Date:11/25/2009)...Nov.25()/PRNewswire-FirstCall/--ErnestB.Remo,Chair...PinkSheets:ADHC),announcedtodaythatitsnewwebsitewe...inginvestorstoeasilyaccesstimelyinformationandsign...edat: http://www.americandiversifiedholdings.com ...wwebsiteallowsustoproviderelevantinformationtoshar...
(Date:11/25/2009)...across the globe have come together to form the In...is to mobilise health professionals across the wor...ange. , The Council will be officially launched ...eries of papers being published by the Lancet on...greenhouse gas emissions, ahead of the UN Climate ...
(Date:11/25/2009)...ican medicinal herb proves effective in animal stu...s) -- An herb called Brazilian mint treats pain as...archers report. , Traditional healers in Brazil... a range of health problems, including headaches, ...st to scientifically prove the pain-relieving prop...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 2Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 3Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 4Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 5Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 6Health News:Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 2Health News:Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 3Health News:American Diversified Holdings Corporation Announces New Website 2Health News:Senior doctors launch global movement to tackle climate change 2
... WORTH, Fla., Jan. 7 Allscripts,announced today t... has,selected the Allscripts Enterprise Electronic... 85 physicians. , (Logo: http://www.newscom.c...nty, including two full-service diagnostic,imaging...
...ch to disclosing medical mistakes shown , , OAKBR...inely disclose nursing errors to their patients, a... The Joint Commission Journal on Quality and Patie...at the bedside of their patients that the study,s ...
...if., Jan. 7 Agito Networks, Inc.(TM), the,company...bility , today,announced that Technology Marketing...azine ( http://www.uc-mag.com ) has named Agito Ne...amAnywhere Mobility Router uniquely fuses,WiFi, ce...
... 7 The Journal of Family Practice Special Editio...sue, Current Clinical Practice for internists, w...ation on quality improvement in medicine. , , Pe...model of medicine. Susan Nedza, MD, MBA talks abou...
... Jan. 7 /PRNewswire-FirstCall/ - MDS Pharma Servic...y and development solutions, today announced the a... and Chief Financial Officer. , Mr. Howard has ext... as CFO at Pharmaceutical Product Development, Inc...
... Become the Gold Standard Adjunctive Treatment for...w Report from Decision Resources , , WALTHAM, Mas... leading research and advisory firms focusing on p...aily. According to U.S. neurologists, a drug of th...
Other Medicine News:Health News:Medical Specialists of the Palm Beaches Selects Allscripts Electronic Health Record to Connect and Automate 85 Physicians 2Health News:Medical Specialists of the Palm Beaches Selects Allscripts Electronic Health Record to Connect and Automate 85 Physicians 3Health News:Medical Specialists of the Palm Beaches Selects Allscripts Electronic Health Record to Connect and Automate 85 Physicians 4Health News:Medical Specialists of the Palm Beaches Selects Allscripts Electronic Health Record to Connect and Automate 85 Physicians 5Health News:Study Finds Failure to Include Nurses in Process of Admitting Errors to Patients, Families 2Health News:Study Finds Failure to Include Nurses in Process of Admitting Errors to Patients, Families 3Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 2Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 3Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 4Health News:Patient Advocacy Is the Focus of December's Current Clinical Practice 2Health News:MDS Pharma Services Names Rudy Howard Chief Financial Officer 2Health News:Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily 2Health News:Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily 3
30 Watt Sealed CO2 Laser System
...ffective line of compact CO2 systems combines port...feature an extremely accurate laser beam, as well ...pecially advantageous for small operating theatres...es. Use of special contact tips and accessories al...
...uper Pulse sealed CO2 surgical lasers offer unmatc...e experience and support services of a company wit...All settings are available at the touch of a finge...mpatible with virtually all microscopes, endoscope...
...a II Glaucoma Laser System is a Q-switched 532 Nd ...increases fluid output, lowering intraocular press...at produces a 3-nanosecond high-energy beam of lig...ism as traditional argon laser therapy (ALT), but ...
Medicine Products: